FDA Investigator Jorge L Guadalupe

Jorge L Guadalupe has inspections in 16 countries as of 20 Sep 2023. Jorge L Guadalupe has collaborated with a combinined 5771 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
97
Last Inspection Date:
20 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Italy, Belgium, Ireland, Sweden, China, Mexico, Germany, Japan, Netherlands, United Kingdom of Great Britain and Northern Ireland, Czechia, Puerto Rico, India, Switzerland
Co-Investigator(s):
Adalberto Cajigas, Adaliz Santaliz Cruz, Agnes M Santori, Alan P Kurtzberg, Alicia M Mozzachio, Alonso, An T Vu, Ana M Rivera, Anastasia G Lolas, Anastasia M Shields, Andrea J Schmidt, Angelica M Hernandez, Anissa M Vargas, Anita R Michael, Ann L Demarco, Anna Lazar, Anna M Brannen, Annette Melendez, Anthony A Charity, Anthony C Warchut, Ariel Cruz Figueroa, Arlene M Badillo, Arsen Karapetyan, Arwa S El Hagrasy, Ashar P Parikh, Ashutosh Rao, PhD, Azza Talaat, Barbara Janine Breithaupt, Barbara M Frazier, Binh T Nguyen, Bo Chi, PhD, Bonita S Chester, Brandon C Heitmeier, Brenda Rivera, Brenda S Zimmer, PhD, Brian R Yaun, Brooke K Higgins, Byungja E Marciante, Carl Lee, Carlos A Medina, Cassandra L Abellard, Catherine J Laufmann, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, CDR Sean T Creighton, Charisse K Green, Charles R Cote, RIC, Cheryl A Clausen, Chilton L Ng, Christina Capacci Daniel, PhD, Christine E Kelley, Christopher S Keating, Chryste Best, Chryste D Best, Claudette D Brooks, Concepcion Cruz, Jr, Conception Cruz, Constance Y Fears, Cynthia J Lee, MS, Cynthia Jim, CSO, Darren S Brown, Dayna I Martinez, Debra I Love, Dell S Moller, Dennis Cantellops Paite, Dianne R Manuel, Djamila Harouaka, Doan T Nguyen, PharmD, Donna Christner, Douglas A Campbell, Douglas C Kovacs, Dr. Carmelo Rosa, Dr. Chunchang Fang, Dr. Jun Liu, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Edwin Martinez, Edwin Melendez, Elena Karnaukhova, PhD, Elizabeth D Connell, Eric M Mueller, PharmD, Eva I Merced Medina, Farhana Khan, Felix Maldonado, Frances L Dejesus, Frances Namuswe, PhD, Frank W Perrella, Fredrick L Fricke, Gavin T Cua, George J Flynn, Gerald B Seaborn, Jr, Gerardo Z Vazquez, German Rivera, Gwyn G Dickinson, Hanisol Fabenelle, Hector Espinet, Hector J Colon Torres, Herbert M Corbello, Iraida Ortiz, Israel Santiago, OCM, Ivis L Negron, Ivis L Negrón, Ivis Lnegron Torres, Jaime E Pares, James A Lane, James C Maclaughlin, James D Planchon, James P Mcreavey, Janet L Bowen, Javier O Vega, Jennifer L Huntington, Jensel L Guadalupe, Joan M Cantellops Figueroa, John A Gonzalez, John D White, Jorge E Martinez, Jorge L Gonzalez, Jorge L Lajara, Jorge Martinez, Jose A Cruz, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, Jose Alopez Rubet, José E Meléndez, Jose E Melendez, DDC, Jose F Pedro, Jose Fpedrode Jesus, Jose Lpez, Jose M Cayuela, Jose Melendez, Jose R Hernandez, Jose R Lopez, Jose Velez, Juan Rjimenez Garcia, Juhong Liu, PhD, Junho Pak, Justine Tomasso, Karen A Wolnik, Karl D Hezel, Katherine Szestypalow, Kejun Cheng, Kenneth H Williams, Kevin A Gonzalez, Kham Phommachanh, Kim Lthomas Cruse, Kimberley A Hoefen, Krishna Ghosh, PhD, Laiza V Garcia, Lareese K Thomas, Larry K Austin, Laura E Garcia, Laurimer Kuilan Torres, LCDR Debra Emerson, LCDR Wilfred A Darang, Leonard H Lavi, Libia M Lugo, Lisa M Lopez, Lourdes Andujar, LT Luis O Rodriguez, Luella J Rossi, Luis A Carrion, Luis A Dasta, Luis M Burgos Medero, Luz N Riveradecruz, Lynda L Perry, PhD, Madushini Dharmasena, PhD, Mamta Gautam Basak, PhD, Marcellinus D Dordunoo, Margaret M Annes, Margarita Santiago, Maria A Ruttell, Maria Joselopez Barragan, PhD, Marian E Ramirez, Marianela Aponte, Marianela Aponte Cruz, Maribel V Juarbe, Maridalia Torres, Maridalia Torres Irizarry, Marie F Morin, Marisal Faberhe, Marisol Faberlle, Marvin D Jones, Mary E Storch, Marybet Lopez, Matthew B Casale, Medina, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Meredith P Soehl, Investigator, Michael A Charles, Michael L Casner, Michael L Chasey, Michael P Sheehan, Michael R Goga, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michelle Y Clark Stuart, Miguel A Martinez, Miguel Hernandez Sanchez, Min Tang, Minerva Rogers, Mra B Kamberem, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Myriam M Sosa, Nadeem I Chaudhry, Nancy G Schmidt, Nancy Rosado, Nicholas L Paulin, Nicole K Trudel, Noreen Muniz, Noreen Muñiz, Pablo Feliciano, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patrick C Klotzbuecher, Patrick L Wisor, Paul E Stein, Paul L Bellamy, Paul L Figarole, Jr, Pratik S Upadhyay, DDC, Rachel C Harrington, Rafael E Cruz, Rafael Nevarez, Rafael Nevarez Nieves, Rakhi B Shah, Ralph H Vocque, Ramon A Hernandez, Rapti D Madurawe, Raquel Gonzalez, Raquel Gonzalez Rivera, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard E Needham, Richard Heath Coats, Robert D Tollefsen, Robert J Ham, Robert J Martin, Robert Rodriguez, Robert Sharpnack, Rochelle L Cross, Rosa J Motta, Rose M Ashley, Roy Baby, Rumany C Penn, PharmD, Russell K Riley, S Lori Brown, PhD MPH, Saied A Asbagh, Samina S Khan, Santos E Camara, Satheesh Thomas, Scott T Ballard, Sharmista Chatterjee, Sharon K Thoma, PharmD, Shirley J Berryman, Simone E Pitts, Sixto M Mercado, Sixto M Mercado Rios, Sixto Mercado Rios, Sneha S Patel, Sonia M Monges, Sony Mathews, Stacie A Woods, State Agency, Stephanie A Slater, MS, Steven B Barber, Steven C Madzo, Steven M Weinman, Steven P Donald, Susan M Jackson, Susan P Bruederle, Susanna E Ford, Analyst, Susant Hadman, Syed N Ali, Tamil Arasu, PhD, Tara G Bizjak, Tara R Gooen, Teresa I Navas, Terri L Dodds, Thao T Kwan, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tiffani D Wilson, Timothy T Kapsala, Tomika L Bivens, Torrance J Slayton, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vaishali J Patel, Vilmary Negron Rodriguez, Viviana Matta, Vlada Matusovsky, Wanda J Torres, Wayne T Smith, Wendy G Tan, PhD, William D Tingley, William Hallett, PhD, Xiaokuang Lai, PhD, Ying Xin Fan, PhD, Ying Zhang, Yong Hu, Youmin Wang, Yumi J Hiramine, Yvesna C Blaise, Zachary L Stamm, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Jorge L Guadalupe's Documents

Publish Date Document Type Title
July, 2003 EIR MSD Organon - EIR, 2003-07-11
October, 2000 EIR Merck Sharp & Dohme BV - EIR, 2000-10-25
October, 2000 FDA 483 Response N.v. Organon - Form 483R, 2000-12-12
August, 2002 FDA 483 CEPH International Corporation - Form 483, 2002-08-23
March, 2001 FDA 483 Fidia Farmaceutici, S.p.A. - Form 483, 2001-03-19
March, 2003 EIR Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - EIR, 2003-03-13
November, 2002 EIR Leo Pharma Manufacturing Italy SRL. - EIR, 2002-11-25
March, 2001 EIR Fidia Farmaceutici, S.p.A. - EIR, 2001-04-26
April, 2002 EIR Wyeth Pharmaceuticals Company - EIR, 2002-04-04
October, 2000 FDA 483 Response Wyeth Pharmaceuticals Company - Form 483R, 2000-10-30
November, 2000 FDA 483 Response Avebe - Form 483R, 2000-11-23
October, 2000 FDA 483 Response Merck Sharp & Dohme BV - Form 483R, 2000-11-06
August, 2002 EIR Lilly del Caribe, Inc. (PR02) - EIR, 2002-08-08
March, 2004 EIR UQUIFA Mexico, S.A. de C.V. - EIR, 2004-04-27
May, 2001 EIR Pfizer Pharmaceuticals LLC - EIR, 2001-05-09
September, 2001 EIR Cardinal Health Manufacturing Services B.V. - EIR, 2001-09-25
March, 2001 FDA 483 Response Fidia Farmaceutici, S.p.A. - Form 483R, 2001-03-29
April, 2002 FDA 483 Wyeth Pharmaceuticals Company - Form 483, 2002-04-04
October, 2001 FDA 483 Kongo Chemical Co. LTD - Form 483, 2001-10-17
April, 2002 FDA 483 Lonza AG - Form 483, 2002-04-29
July, 2003 FDA 483 Response N.V. Organon - Form 483R, 2003-11-04
August, 2002 FDA 483 Response CEPH International Corporation - Form 483R, 2002-09-05
October, 2000 EIR Wyeth Pharmaceuticals Company - EIR, 2000-10-10
October, 2002 FDA 483 Response AbbVie Deutschland GmbH & Co KG - Form 483R, 2002-11-20
November, 2002 FDA 483 SCHERING S.A - Form 483, 2002-11-07
November, 2003 EIR Northeast Pharmaceutical Group Co., Ltd. - EIR, 2003-12-02
March, 2000 EIR MSD International GmbH (Puerto Rico Branch) LLC - EIR, 2000-03-17
July, 2004 EIR Abbott Diagnostics International, Ltd. - EIR, 2004-07-16
June, 2001 FDA 483 Abbott Chemical Plant, Inc. - Form 483, 2001-06-12
June, 2004 EIR CATALENT PR HUMACAO, INC./dba CATALENT PHARMA SOLUTIONS, LLC - EIR, 2004-06-16
October, 2002 FDA 483 Response Bayer Healthcare Manufacturing Srl - Form 483R, 2002-10-31
July, 2003 EIR N. V. Organon - EIR, 2003-07-18
May, 2003 EIR Cardinal Health Manufacturing Services B.V. - EIR, 2003-05-08
March, 2003 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2003-03-13
June, 2001 EIR AbbVie Ltd - EIR, 2001-06-12
February, 2001 EIR McNeil Healthcare LLC. - EIR, 2001-02-13
February, 2000 FDA 483 Janssen Ortho LLC - Form 483, 2000-02-18
October, 2000 FDA 483 Wyeth Pharmaceuticals Company - Form 483, 2000-10-10
March, 2004 FDA 483 Response UQUIFA Mexico, S.A. de C.V. - Form 483R, 2004-04-14
April, 2000 FDA 483 Wyeth Pharmaceuticals Company - Form 483, 2000-04-27
May, 2003 FDA 483 Cardinal Health Manufacturing Services B.V. - Form 483, 2003-05-08
November, 2003 EIR Shanghai Ziyuan Pharmaceutical Co. Ltd. - EIR, 2003-11-24
April, 2004 EIR Bristol-Myers Squibb Manufacturing Company Unlimited Company - EIR, 2004-04-26
October, 2003 FDA 483 Janssen Ortho LLC - Form 483, 2003-10-15
February, 2000 EIR Janssen Ortho LLC - EIR, 2000-02-18
October, 2003 EIR Janssen Ortho LLC - EIR, 2003-10-15
October, 2000 EIR N.v. Organon - EIR, 2000-10-20
February, 2001 FDA 483 McNeil Healthcare LLC. - Form 483, 2001-02-13
October, 2002 EIR Bayer Healthcare Manufacturing Srl - EIR, 2002-10-31
April, 2002 EIR Lonza AG - EIR, 2002-04-29
April, 2002 FDA 483 Response Lonza AG - Form 483R, 2002-05-02
November, 2000 EIR Avebe - EIR, 2000-11-01
March, 2004 FDA 483 Response Fermic, S.A. de C.V. - Form 483R, 2004-03-31
October, 2001 FDA 483 Yuki Gosei Kogyo Co. LTD - Form 483, 2001-10-12
March, 2004 EIR Janssen Ortho LLC - EIR, 2004-03-04
October, 2000 FDA 483 Merck Sharp & Dohme BV - Form 483, 2000-10-25
September, 2002 EIR MSD International GmbH (Puerto Rico Branch) LLC - EIR, 2002-09-09
October, 2000 FDA 483 MSD Organon - Form 483, 2000-10-18
August, 2002 EIR CEPH International Corporation - EIR, 2002-08-23
January, 2003 EIR Bristol Myers Squibb Manufacturing, Co. - EIR, 2003-01-29
November, 2002 FDA 483 Response Leo Pharma Manufacturing Italy SRL. - Form 483R, 2002-12-02
February, 2004 EIR Knoll LLC - EIR, 2004-02-06
October, 2002 EIR AbbVie Deutschland GmbH & Co KG - EIR, 2002-10-25
March, 2004 EIR Fermic, S.A. de C.V. - EIR, 2007-06-22
February, 2004 FDA 483 Knoll LLC - Form 483, 2004-02-06
October, 2002 FDA 483 AbbVie Deutschland GmbH & Co KG - Form 483, 2002-10-25
October, 2003 FDA 483 Response Janssen Ortho LLC - Form 483R, 2003-12-19
November, 2003 FDA 483 Response Shanghai Ziyuan Pharmaceutical Co. Ltd. - Form 483R, 2004-01-26
July, 2003 EIR N.V. Organon - EIR, 2003-07-17

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more